Cargando…

Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis()

Detalles Bibliográficos
Autores principales:	Lippi, Giuseppe, Lavie, Carl J., Sanchis-Gomar, Fabian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127395/ https://www.ncbi.nlm.nih.gov/pubmed/32169400 http://dx.doi.org/10.1016/j.pcad.2020.03.001

Ejemplares similares

Cardiac Injury in COVID-19–Echoing Prognostication
por: Lavie, Carl J., et al.
Publicado: (2020)

Cardiac troponin elevation in patients with influenza virus infections
por: Lippi, Giuseppe, et al.
Publicado: (2021)

Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis
por: Aggarwal, Gaurav, et al.
Publicado: (2020)

Coronavirus Disease 2019–Associated Coagulopathy
por: Lippi, Giuseppe, et al.
Publicado: (2021)

“Ultra-sensitive” cardiac troponins: Requirements for effective implementation in clinical practice
por: Lippi, Giuseppe, et al.
Publicado: (2018)

Exploring the association between extra-cardiac troponin elevations and risk of future mortality
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Cardiac Biomarkers in COVID-19: A Narrative Review
por: Lippi, Giuseppe, et al.
Publicado: (2021)

Coronavirus disease 2019 (COVID-19): the portrait of a perfect storm
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Potential drawbacks of frequent asymptomatic coronavirus disease 2019 (COVID-19) testing
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Updates on laboratory investigations in coronavirus disease 2019 (COVID-19)
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

SARS-CoV-2 recurrent RNA positivity after recovering from coronavirus disease 2019 (COVID-19): a meta-analysis
por: Mattiuzzi, Camilla, et al.
Publicado: (2020)

Estimating Worldwide Impact of Low Physical Activity on Risk of Developing Ischemic Heart Disease-Related Disability: An Updated Search in the 2019 Global Health Data Exchange (GHDx)
por: Lippi, Giuseppe, et al.
Publicado: (2022)

Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

In reply— Association of Renin-Angiotensin System Blockers with Outcomes in Patients With COVID-19
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Fit Is It in COVID-19, Future Pandemics, and Overall Healthy Living
por: Lavie, Carl J., et al.
Publicado: (2021)

In Reply — Cardiorespiratory Fitness Attenuates the Impact of Risk Factors Associated With COVID-19 Hospitalization
por: Lavie, Carl J., et al.
Publicado: (2021)

Improved efficiency and cost reduction in the emergency department by replacing contemporary sensitive with high-sensitivity cardiac troponin immunoassay
por: Aloe, Rosalia, et al.
Publicado: (2019)

Estimating the burden of mental health impairment after COVID-19
por: Mattiuzzi, Camilla, et al.
Publicado: (2022)

Benzodiazepines consumption may have increased during the COVID-19 pandemic
por: Mattiuzzi, Camilla, et al.
Publicado: (2022)

Do Antioxidant Vitamins Prevent Exercise-Induced Muscle Damage? A Systematic Review
por: Martinez-Ferran, María, et al.
Publicado: (2020)

In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

COVID-19 and smoking: Considerations after two years
por: Lippi, Giuseppe, et al.
Publicado: (2023)

Active smoking and COVID-19: a double-edged sword
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Putative impact of the COVID-19 pandemic on anxiety, depression, insomnia and stress
por: Lippi, Giuseppe, et al.
Publicado: (2021)

Web searches for anxiolytic drugs during the COVID-19 outbreak in the USA
por: Lippi, Giuseppe, et al.
Publicado: (2022)

COVID-19: unravelling the clinical progression of nature’s virtually perfect biological weapon
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Protecting against sedentary lifestyle, left atrial enlargement and atrial fibrillation
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2022)

Physical activity - an important preanalytical variable
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2014)

Procalcitonin in inflammatory bowel disease: Drawbacks and opportunities
por: Lippi, Giuseppe, et al.
Publicado: (2017)

Influence of chronic training workload on the hematological profile: a pilot study in sedentary people, amateur and professional cyclists
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Statins and other drugs: Facing COVID-19 as a vascular disease
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Intermittent hypobaric hypoxia applicability in myocardial infarction prevention and recovery
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2012)

Red blood cell distribution width: A marker of anisocytosis potentially associated with atrial fibrillation
por: Lippi, Giuseppe, et al.
Publicado: (2019)

Updated overview on interplay between physical exercise, neurotrophins, and cognitive function in humans
por: Lippi, Giuseppe, et al.
Publicado: (2020)

CT-Determined Maximum Pulmonary Artery to Ascending Aorta Diameter Ratio in Nonsevere COVID-19 Patients
por: Abosamak, Mohammed Fawzi, et al.
Publicado: (2021)

Is COVID-19 impacting prostate cancer screening? A survey of prostate-specific antigen test requests during a local outbreak
por: Ferrari, Anna, et al.
Publicado: (2021)

Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Repeated Testing in SARS-CoV-2 Infection
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Brief update on coronavirus disease 2019 (COVID-19) diagnostics
por: Lippi, Giuseppe
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rr1tj7a3iq9qk1r8hhueqevlk8